课题基金 / 基金详情

Radiofrequency ablation for pulmonary aspergilloma

Radiofrequency ablation for pulmonary aspergilloma
射频消融术治疗肺曲菌瘤
批准号:
22591370
负责人:
HIRAKI Takao
金额:
$1.58万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2010
资助国家:
日本
项目状态:
已结题
起止时间:
2010 至 2012

项目摘要

项目成果

相似基金

相关文献

中文摘要
翻译
采用射频消融术治疗肺曲菌瘤。手术安全完成,无任何不良事件。术后连续随访26个月CT扫描显示消融区持续缩小。16个月时,对消融区进行活检,发现标本主要由丰富的纤维化组织和部分菌丝组成。因此,本研究表明射频消融术作为肺曲菌瘤的治疗是安全有效的。
英文摘要
Radiofrequency ablation was performed for pulmonary aspergilloma. The procedure was safely done without any adverse events. Serial follow-up CT scan up to 26 months after the procedure showed that ablation zone continued to shrink. At 16 months, biopsy of the ablation zone was performed and revealed that the specimen was consisted mostly of abundant fibrotic tissue and partly of hypha. Thus, this study showed radiofrequency ablation was safe and effective as a treatment of pulmonary aspergilloma.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1016/j.jvir.2011.02.030
发表时间: 2011-06-01
期刊: JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY
影响因子: 2.9
作者: [Hiraki, Takao, Yamakado, Koichiro, Kanazawa, Susumu]
通讯作者: Kanazawa, Susumu
Phrenic nerve injury after radiofrequency ablation of lung tumors: retrospective evaluation of the incidence and risk factors.
肺部肿瘤射频消融术后膈神经损伤:发生率和危险因素的回顾性评估。
DOI: 10.1016/j.jvir.2012.02.014
发表时间: 2012
期刊: J Vasc Interv Radiol
影响因子: 2.9
作者: [渡邊春夫, 兼松雅之, 他, Tada A, Matsui Y]
通讯作者: Matsui Y
DOI: --
发表时间: 2015
期刊: Clinicin
影响因子: --
作者: [Takashi Tanaka, Hideo Gobara, Koji Tomita, Takao Hiraki, Takehiro Tanaka, Susumu Kanazawa., 平木隆夫]
通讯作者: 平木隆夫
CTガイドのIVR-Ablation-
CT引导IVR-消融-
DOI: --
发表时间: 2011
期刊:
影响因子: --
作者: [藤原顕, 加藤隆司, ほか, 平木隆夫]
通讯作者: 平木隆夫
18
    海外基金